The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens
@article{JGO51245, author = {Paul H. Sugarbaker and Kurt Van der Speeten}, title = {The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens}, journal = {Journal of Gastrointestinal Oncology}, volume = {12}, number = {Suppl 1}, year = {2021}, keywords = {}, abstract = {}, issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/51245} }